Option chain shows key data for Roche Holding's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Roche Holding.

Roche Holding (OTC:RHHBF) Stock, Option Chain

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Roche

Equities

News

Media

RHHBF

RHHBY

Roche Holding AG reportedly says no layoffs planned. CEO Schinecker provides pipeline updates including potential anti-obesity drug by 2029.

Roche CEO Reassures No Job Cuts Despite Challenges: Report

Novartis

Health Care

Markets

General

Novartis reportedly plans to cut 680 development jobs worldwide, separate from an 8,000-employee restructuring, aiming to reshape its workforce and tap local talent pools.

Novartis To Axe 680 Development Jobs Amid Global Reshuffle: Report

Penny Stocks

Movers

Trading Ideas

LMDX

RHHVF

Friday, LumiraDx Limited (NASDAQ: LMDX) appointed joint administrators for two subsidiaries.

Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M

ROCHE HOLDING LTD ORD by Roche Holding Ltd

Comments

Roche Holding

Roche Holding (RHHBF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga